Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions

Bibliographic Details
Main Authors:	Bukan, N. (Author), Sancak, B. (Author), Coskun, U. (Author), Günel, N. (Author), Yucel, A. (Author), Ozenirler, S. (Author), Unal, A. (Author)
Format:	Article
Language:	Slovak English
Subjects:	interleukín 6 nádory pečene nádorové metastázy faktor rastový, hepatocytov hepatóm postup choroby nádory prsníka články z novín a časopisov

Similar Items